What does this video actually claim?
The video itself doesn't make explicit health claims, but the hashtags tell the story. Carolina Tejera promotes a clinic offering ipamorelin and growth hormone therapy alongside testosterone and hormone replacement treatments. The #ipamorelin and #growthhormone tags suggest these peptides can enhance wellness and anti-aging.
This is classic peptide clinic marketing. Mix legitimate hormones like testosterone with unproven peptides, then imply they're all equally effective. The 62.2K views show how well this approach works for audience reach.
Is ipamorelin actually proven to work?
The evidence is surprisingly thin for such a popular peptide. Ipamorelin does increase growth hormone release in controlled studies, but that doesn't translate to real-world benefits. A 2005 study by Raun et al. in European Journal of Endocrinology showed GH increases in healthy adults, but measured no body composition changes.
The FDA has never approved ipamorelin for any medical use. It exists in a regulatory gray area where clinics can prescribe it off-label. Most peptide therapy research involves small studies with unclear long-term safety data.
Growth hormone itself has proven benefits for GH-deficient patients, but using peptides to boost GH in healthy adults is different. The risk-benefit calculation changes completely when you're not treating an actual deficiency.
What are the real risks here?
Peptide clinics rarely discuss the downsides honestly. Ipamorelin can cause injection site reactions, headaches, and flushing in about 10-15% of users based on clinic reports. More concerning are the unknown long-term effects of artificially stimulating growth hormone.
The bigger issue is quality control. Many peptide suppliers operate with minimal oversight. A 2019 analysis by Supplement Safety found that 23% of peptide products contained different compounds than labeled.
Growth hormone excess, even mild, can increase cancer risk over time. The European Prospective Investigation into Cancer and Nutrition found elevated IGF-1 levels associated with 20-30% higher risk for several cancers.
How does this compare to proven treatments?
Testosterone replacement therapy, also mentioned in the hashtags, actually has solid evidence when properly indicated. The Testosterone Trials (Snyder et al., NEJM, 2016) showed real benefits for men with clinically low testosterone levels.
The contrast is stark. TRT has decades of research, FDA approval, and established protocols. Ipamorelin has none of these things. Clinics bundle them together to make peptides seem equally legitimate.
If you're genuinely concerned about aging or energy, proven interventions exist. Regular exercise provides many of the same benefits people seek from peptides, with much better safety data.
What should you actually know?
Peptide therapy isn't automatically dangerous, but it's not the miracle cure social media suggests. The research simply doesn't support most anti-aging claims yet. Clinical trials are ongoing, but we're years away from definitive answers.
If you're considering peptide therapy, work with providers who discuss limitations honestly. Anyone promising dramatic results without mentioning risks is selling, not treating.
The most responsible approach? Address the basics first. Sleep, nutrition, and exercise provide proven benefits without the uncertainty and cost of experimental peptides. Legitimate hormone therapy exists for actual deficiencies.